Get the Stockscreener App
7.70
6.06%
0.44
Treace Medical Concepts Inc stock is traded at $7.70, with a volume of 423.64K.
It is up +6.06% in the last 24 hours and up +30.73% over the past month.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
See More
Previous Close:
$7.26
Open:
$7.3
24h Volume:
423.64K
Relative Volume:
1.27
Market Cap:
$486.43M
Revenue:
$198.53M
Net Income/Loss:
$-63.68M
P/E Ratio:
-7.5328
EPS:
-1.0222
Net Cash Flow:
$-41.50M
1W Performance:
+11.76%
1M Performance:
+30.73%
6M Performance:
-17.82%
1Y Performance:
+24.19%
1-Day Range:
$7.18
$7.78
1-Week Range:
$6.80
$7.78
52-Week Range:
$4.54
$10.79
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts Inc
Sector
Industry
Phone
(904) 373-5940
Address
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
7.70 | 444.74M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-25 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-31-24 | Initiated | Lake Street | Buy |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| May-16-24 | Downgrade | UBS | Buy → Neutral |
| May-08-24 | Downgrade | BTIG Research | Buy → Neutral |
| May-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-08-24 | Downgrade | Stifel | Buy → Hold |
| May-08-24 | Downgrade | Truist | Buy → Hold |
| Sep-29-23 | Initiated | UBS | Buy |
| May-01-23 | Initiated | Truist | Buy |
| Apr-11-23 | Initiated | Stephens | Equal-Weight |
| May-12-22 | Initiated | BTIG Research | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-18-21 | Initiated | JP Morgan | Overweight |
| May-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-21 | Initiated | SVB Leerink | Outperform |
| May-18-21 | Initiated | Stifel | Buy |
View All
Treace Medical Concepts Inc Stock (TMCI) Latest News
Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Shares Leap 27% Yet They're Still Not Telling The Full Story - simplywall.st
Connor Clark & Lunn Investment Management Ltd. Raises Position in Treace Medical Concepts, Inc. $TMCI - MarketBeat
Treace Medical Concepts Inc. Forms Double Bottom Pattern — Eyes on BreakoutProduct Launch & Fast Entry Momentum Alerts - Newser
Visual trend scoring systems applied to Treace Medical Concepts Inc.Market Performance Recap & Real-Time Volume Trigger Notifications - Newser
Key resistance and support levels for Treace Medical Concepts Inc.July 2025 Summary & Long-Term Growth Portfolio Plans - Newser
Is Treace Medical Concepts Inc. trending in predictive chart modelsWeekly Investment Recap & Community Verified Trade Alerts - Newser
Treace Medical Concepts Inc. Added to High Probability Setup ListJuly 2025 Macro Moves & Real-Time Market Trend Scan - beatles.ru
What earnings revisions data tells us about Treace Medical Concepts Inc.2025 Breakouts & Breakdowns & Safe Entry Zone Identification - Newser
Risk vs reward if holding onto Treace Medical Concepts Inc.Quarterly Investment Review & Free Reliable Trade Execution Plans - Newser
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Important Notice to Long-Term Shareholders of DoubleVerify - GlobeNewswire
Treace Medical Concepts Inc. stock prediction for this weekTrade Exit Summary & Real-Time Buy Zone Alerts - Newser
Does Treace Medical Concepts Inc. fit your quant trading modelQuarterly Earnings Summary & Reliable Momentum Entry Alerts - Newser
Using portfolio simulators with Treace Medical Concepts Inc. includedJuly 2025 Movers & Safe Capital Investment Plans - Newser
How to interpret RSI for Treace Medical Concepts Inc. stockJuly 2025 Market Mood & Safe Entry Trade Reports - Newser
How high can Treace Medical Concepts Inc. stock go2025 Macro Impact & Low Risk Entry Point Tips - Newser
Published on: 2025-08-18 22:09:59 - Newser
Evaluating Treace Medical Concepts Inc. with trendline analysisPortfolio Performance Summary & Capital Protection Trading Alerts - Newser
Competitive Positioning of Treace Medical Concepts Inc.: Is It Leading or LaggingJuly 2025 Catalysts & Risk Controlled Stock Pick Alerts - Newser
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Analyzing Treace Medical Concepts Inc. with risk reward ratio chartsInflation Watch & Fast Entry Momentum Alerts - Newser
Key metrics from Treace Medical Concepts Inc.’s quarterly dataMarket Trend Summary & Accurate Trade Setup Notifications - Newser
Treace Medical Concepts: Positive Q2 Earnings Call Highlights - MSN
Historical volatility pattern of Treace Medical Concepts Inc. visualizedChart Signals & Low Volatility Stock Suggestions - Newser
Is Treace Medical Concepts Inc. stock ready for a breakoutWeekly Stock Analysis & Risk Managed Investment Strategies - Newser
Is Treace Medical Concepts Inc. forming a reversal patternJuly 2025 Breakouts & Technical Buy Zone Confirmations - Newser
Backtesting results for Treace Medical Concepts Inc. trading strategiesEarnings Recap Summary & Capital Efficiency Focused Ideas - Newser
What recovery options are there for Treace Medical Concepts Inc.July 2025 News Drivers & Weekly Chart Analysis and Trade Guides - Newser
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Investors to Inquire about Securities Investigation - ACCESS Newswire
Treace Medical Concepts (NASDAQ:TMCI) Releases Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Arcadia Wealth Management Inc. Takes Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
UBS Group Reaffirms Neutral Rating for Treace Medical Concepts (NASDAQ:TMCI) - MarketBeat
Stifel Nicolaus Lowers Treace Medical Concepts (NASDAQ:TMCI) Price Target to $6.00 - MarketBeat
Investigation announced for Investors who hold shares of Treace - openPR.com
SEC Filings Archive 2025-08-12Historical 10-K, 10-Q, 8-K Forms - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Reach Out - ACCESS Newswire
Treace Medical anticipates 7–10% revenue growth in 2025 while launching next-gen bunion solutions - MSN
What makes Treace Medical Concepts Inc. stock price move sharplyShort Term Risk Controlled Alerts - beatles.ru
Analysts Have Been Trimming Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Price Target After Its Latest Report - Yahoo Finance
How Treace Medical Concepts Inc. stock performs during market volatilityShort Term Gain Strategy with AI Logic - Newser
Insider Stock Buying Reaches US$1.80m On Treace Medical Concepts - 富途牛牛
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported, And Analysts Assigned A US$8.35 Price Target - simplywall.st
Treace Medical Concepts Inc Stock (TMCI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Treace Medical Concepts Inc Stock (TMCI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Scanlan Sean F. | Chief Innovation Officer |
Mar 17 '25 |
Option Exercise |
1.05 |
50,000 |
52,500 |
414,081 |
| Scanlan Sean F. | Chief Innovation Officer |
Mar 17 '25 |
Sale |
7.97 |
50,000 |
398,460 |
364,081 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):